Daniel Bensen

CIK: 0001880946

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)11 (91.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (8.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TYRA

Tyra Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

TYRA
Tyra Biosciences, Inc.
Feb 12, 2026
Sale(S)
Direct
2.1K shares at avg. $31.50$67K
TYRA
Tyra Biosciences, Inc.
Feb 12, 2026
Sale(S)
Direct
5.9K shares at avg. $33.37$196K
TYRA
Tyra Biosciences, Inc.
Jan 12, 2026
Sale(S)
Direct
1K shares at avg. $29.08$30K
TYRA
Tyra Biosciences, Inc.
Jan 12, 2026
Sale(S)
Direct
7K shares at avg. $28.44$199K
TYRA
Tyra Biosciences, Inc.
Dec 12, 2025
Sale(S)
Direct
8K shares at avg. $22.64$181K
TYRA
Tyra Biosciences, Inc.
Nov 19, 2025
Sale(S)
Direct
50K shares at avg. $16.32$815K
TYRA
Tyra Biosciences, Inc.
Nov 18, 2025
Sale(S)
Direct
75.6K shares at avg. $16.07$1.2M
TYRA
Tyra Biosciences, Inc.
Nov 17, 2025
Sale(S)
Direct
1.5K shares at avg. $17.07$26K
TYRA
Tyra Biosciences, Inc.
Nov 17, 2025
Sale(S)
Direct
18.6K shares at avg. $16.11$299K
TYRA
Tyra Biosciences, Inc.
Nov 14, 2025
Sale(S)
Direct
110.2K shares at avg. $16.02$1.8M
TYRA
Tyra Biosciences, Inc.
Nov 13, 2025
Sale(S)
Direct
1.1K shares at avg. $16.00$18K
TYRA
Tyra Biosciences, Inc.
Aug 7, 2025
Award(A)
Stock Option (Right to Buy)
Direct
170K shares-

		Type	Shares	Price		Ownership
Feb 12, 2026	TYRA Tyra Biosciences, Inc.	Sale(S)	2,128	$31.50	$67,036	Direct
Feb 12, 2026	TYRA Tyra Biosciences, Inc.	Sale(S)	5,872	$33.37	$195,929	Direct
Jan 12, 2026	TYRA Tyra Biosciences, Inc.	Sale(S)	1,017	$29.08	$29,575	Direct
Jan 12, 2026	TYRA Tyra Biosciences, Inc.	Sale(S)	6,983	$28.44	$198,610	Direct
Dec 12, 2025	TYRA Tyra Biosciences, Inc.	Sale(S)	8,000	$22.64	$181,159	Direct
Nov 19, 2025	TYRA Tyra Biosciences, Inc.	Sale(S)	49,956	$16.32	$815,297	Direct
Nov 18, 2025	TYRA Tyra Biosciences, Inc.	Sale(S)	75,633	$16.07	$1,215,627	Direct
Nov 17, 2025	TYRA Tyra Biosciences, Inc.	Sale(S)	1,500	$17.07	$25,607	Direct
Nov 17, 2025	TYRA Tyra Biosciences, Inc.	Sale(S)	18,572	$16.11	$299,191	Direct
Nov 14, 2025	TYRA Tyra Biosciences, Inc.	Sale(S)	110,228	$16.02	$1,765,489	Direct
Nov 13, 2025	TYRA Tyra Biosciences, Inc.	Sale(S)	1,111	$16.00	$17,780	Direct
Aug 7, 2025	TYRA Tyra Biosciences, Inc.	Award(A) Stock Option (Right to Buy)	170,000	-	-	Direct

1-12 of 12 transactions

About Bensen Daniel

Bensen Daniel (SEC CIK 0001880946) files insider reports with the SEC as Chief Discovery Officer of Tyra Biosciences, Inc. (TYRA).

Signal8 holds 6 ownership filings by Bensen Daniel, all Form 4s, filed between Aug 7, 2025 and Feb 13, 2026. Those filings report 12 transactions, from Aug 7, 2025 to Feb 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bensen Daniel's filings is in CARLSBAD, CA.

Recent filings by Bensen Daniel

Feb 12, 2026: Open-market sales of TYRA shares (2 lines, Form 4, code S).
Jan 12, 2026: Open-market sales of TYRA shares (2 lines, Form 4, code S).
Dec 12, 2025: Open-market sale of TYRA shares (Form 4, code S).
Nov 19, 2025: Open-market sale of TYRA shares (Form 4, code S).
Nov 18, 2025: Open-market sale of TYRA shares (Form 4, code S).

Other insiders filing for Tyra Biosciences, Inc. (TYRA)

Harris Todd, President and CEO
Rueb Yuliya, Vice President, Finance (PAO)
Fuhrman Alan, Chief Financial Officer
RA CAPITAL MANAGEMENT, L.P., Director
Verjee Rehan, Director
Moran Susan, Director

How to read Form 4 transaction codes